Abstract
Telmisartan has the dual ability to inhibit angiotensin II type 1 receptors and activate peroxisome proliferator-activated receptor gamma (PPAR), especially as a selective PPAR modulator that does not strongly promote adipogenesis for weight gain. Accordingly, Telmisartan is expected to provide beneficial effects for glucose and lipid metabolism without causing obesity. In the present study, we examined the effects of Telmisartan in patients with type 2 diabetes and metabolic syndrome. Thirty-two patients enrolled in this study were administered 40 mg per day of Telmisartan for 6 months. Telmisartan treatment significantly reduced systolic and diastolic blood pressure accompanied by induction of plasma renin activity (PRA) and reduction of serum aldosterone concentration and significantly decreased waist circumference, body mass index (BMI), and triglycerides (TG). In the 16 patients who did not take sulfonylurea, fasting plasma glucose (FPG) decreased and HbA1c significantly decreased from 3 months to 6 months. The results provide evidence that Telmisartan may improve glucose and lipid metabolism with the reduction in visceral fat mass in patients with type 2 diabetes and metabolic syndrome.:
References
Mar 1, 1992·The American Journal of the Medical Sciences·K FujimotoK Kurata
Jul 1, 1985·Diabetologia·D R MatthewsR C Turner
Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Mar 10, 2004·Hypertension·Stephen C BensonTheodore W Kurtz
Jun 23, 2004·Lancet·Stevo JuliusUNKNOWN VALUE trial group
Aug 11, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Giuseppe DerosaRoberto Fogari
Jan 29, 2005·Diabetes Care·Sachiko HonjoHiroyuki Koshiyama
Mar 1, 2005·Diabetes Care·Yoshitaka MiuraYutaka Oiso
Jun 29, 2005·Circulation·Salim YusufUNKNOWN Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity Program Investigators
Jan 10, 2006·Drugs·Anna J Battershill, Lesley J Scott
Mar 28, 2006·The American Journal of Medicine·Theodore W Kurtz
Mar 29, 2006·Hypertension·Ken SugimotoTheodore W Kurtz
May 24, 2006·Hypertension·Kana ArakiHironobu Yoshimatsu
Jan 24, 2007·Diabetes Research and Clinical Practice·Isao UsuiMasashi Kobayashi
Mar 14, 2007·Journal of Hypertension·Michio ShimabukuroTakeshi Shimabukuro
May 29, 2007·Advances in Therapy·Yutaka MoriNaoko Tajima
May 30, 2007·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T InoueK Node
Aug 1, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Uta SyrbeYvonne Dörffel
Sep 23, 2008·Metabolism: Clinical and Experimental·Shinji MakitaMotoyuki Nakamura
Citations
Jan 29, 2019·Metabolic Syndrome and Related Disorders·Sinem KiyiciErcan Tuncel
Apr 18, 2013·The Journal of Biological Chemistry·Aung ThanPeng Chen
Jul 22, 2020·Obesity·Chia Siang Kow, Syed Shahzad Hasan
Jul 1, 2021·Oxford Open Immunology·Felix Clemens RichterSarah Hulin-Curtis